Sanofi India Limited SANOFI
NSE · India · Health Technology
INR 3,040.00-17.00 (-0.56%)
Market open· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Sanofi India Ltd (BOM:500674) delivers robust Q2 performance with double-digit diabetes growth and strong margin expansion, despite partnership segment headwinds.
Sanofi India Ltd (BOM:500674) reports steady growth in its diabetes segment, while addressing challenges in partnership sales and cost management.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.
